{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T01:40:16Z","timestamp":1679276416082},"reference-count":41,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,8]]},"abstract":"Object<\/jats:italic>. It is well known that the central nervous system (CNS) is an immunologically privileged site. To characterize CD8+<\/jats:sup> tumor-infiltrating lymphocytes (TILs) recovered from the CNS, the authors compared these cells with TILs recovered from subcutaneous tissue by using a B7.1<\/jats:italic> gene\u2014modified tumor implantation model.<\/jats:p>\nMethods<\/jats:italic>. The authors established a B7.1<\/jats:italic> gene\u2014modified EL4 murine lymphoma cell line (EL4-B7.1) and implanted the cells into the CNS to observe the duration of tumor-free survival. Although EL4-B7.1 cells were completely rejected in a subcutaneous implantation model, 40% of animals died after the CNS implantation (all animals in which the parent tumor was implanted died within 16 days). Therefore, the authors isolated TILs from each implantation site and analyzed the expressions of activation antigens CD25 and CD69 by performing the anti-CD8 magnetic beads separation method and flow cytometric analysis. After implantation of the parent tumor, there was no difference in the number of TILs from each site (CD25 1.7\u20133.2%, CD69 21.9\u201334.3%). After implantation of the B7.1<\/jats:italic>-modified tumor, the CD25-expressing TIL population from the subcutaneous site was 4.68 times higher than that from the CNS site (17.8% compared with 3.8%). Based on these findings, the authors used a mitomycin C\u2014treated EL4-B7.1 subcutaneous vaccination with various protocols. Vaccination before tumor challenge was sufficient to prevent the development of the tumor. For animals with established tumor, the vaccination protocol was able to prolong host survival (p = 0.0053).<\/jats:p>\nConclusions<\/jats:italic>. The data clearly demonstrate that the CNS environment fails to activate CD8+<\/jats:sup> TILs fully. These are the first data indicating in detail a difference between CD8+<\/jats:sup> TILs from the CNS and those from other sites based on a B7.1<\/jats:italic>-modified tumor model.<\/jats:p>","DOI":"10.3171\/jns.2002.97.2.0432","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:45:03Z","timestamp":1242236703000},"page":"432-440","source":"Crossref","is-referenced-by-count":2,"title":["Failure of B7.1-modified tumor to evoke full activation of CD8+ tumor-infiltrating lymphocytes in the central nervous system: prevention of parental tumor growth in the subcutaneous environment"],"prefix":"10.3171","volume":"97","author":[{"given":"Hiromichi","family":"Ando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Saio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Tamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.4049\/jimmunol.164.9.4689","article-title":"Characterization of human inducible costimulator ligand expression and function.","volume":"164","author":"Aicher","year":"2000"},{"key":"b2","series-title":"Cancer Immunol Immunother","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s002620050463","article-title":"Tumor antigen presentation: changing the rules.","volume":"46","author":"Armstrong","year":"1998"},{"key":"b3","series-title":"Curr Oncol Rep","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11912-000-0067-z","article-title":"Gene therapy for brain tumors.","volume":"2","author":"Bansal","year":"2000"},{"key":"b4","series-title":"Nature","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/377630a0","article-title":"A role for CD95 ligand in preventing graft rejection.","volume":"377","author":"Bellgrau","year":"1995"},{"key":"b5","series-title":"Curr Opin Immunol","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/0952-7915(95)80067-0","article-title":"CD28 and apoptosis.","volume":"7","author":"Boise","year":"1995"},{"key":"b6","series-title":"J Immunol","first-page":"2834","article-title":"Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.","volume":"158","author":"Cayeux","year":"1997"},{"key":"b7","series-title":"Curr Opin Immunol","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0952-7915(97)80087-8","article-title":"Co-stimulation in T cell responses.","volume":"9","author":"Chambers","year":"1997"},{"key":"b8","series-title":"Nat Immunol","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.","volume":"2","author":"Chapoval","year":"2001"},{"key":"b9","series-title":"J Neurooncol","first-page":"217","article-title":"Anti-tumor gene therapy.","volume":"31","author":"Cirielli","year":"1997"},{"key":"b10","series-title":"Cancer Res","first-page":"4980","article-title":"B7-1 and interleukin 12 synergistically induce effective antitumor immunity.","volume":"55","author":"Coughlin","year":"1995"},{"key":"b11","series-title":"Nat Immunol","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/85251","article-title":"The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.","volume":"2","author":"Coyle","year":"2001"},{"key":"b12","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/sj.cgt.7700268","article-title":"The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.","volume":"7","author":"Douin-Echinard","year":"2000"},{"key":"b13","series-title":"Cancer Immunol Immunother","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s002620050374","article-title":"Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice.","volume":"44","author":"Enomoto","year":"1997"},{"key":"b14","series-title":"Science","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1126\/science.7694362","article-title":"Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.","volume":"262","author":"Freeman","year":"1993"},{"key":"b15","series-title":"Science","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1126\/science.7694363","article-title":"Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.","volume":"262","author":"Freeman","year":"1993"},{"key":"b16","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.","volume":"192","author":"Freeman","year":"2000"},{"key":"b17","series-title":"Curr Opin Immunol","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/0952-7915(94)90017-5","article-title":"Autoimmunity in the eye and its regulation.","volume":"6","author":"Gery","year":"1994"},{"key":"b18","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/00006123-199910000-00028","article-title":"Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.","volume":"45","author":"Glick","year":"1999"},{"key":"b19","series-title":"Cancer Res","first-page":"5552","article-title":"Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.","volume":"54","author":"Hodge","year":"1994"},{"key":"b20","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3171\/jns.1994.80.1.0090","article-title":"Generation of cytotoxic immune responses during the progression of a rat glioma.","volume":"80","author":"Holladay","year":"1994"},{"key":"b21","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1084\/jem.183.3.769","article-title":"Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?","volume":"183","author":"Huang","year":"1996"},{"key":"b22","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<714::AID-IJC15>3.0.CO;2-Q","article-title":"Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.","volume":"82","author":"Joki","year":"1999"},{"key":"b23","series-title":"Nat Immunol","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-I and inhibits T cell activation.","volume":"2","author":"Latchman","year":"2001"},{"key":"b24","series-title":"Annu Rev Immunol","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.immunol.14.1.233","article-title":"CD28\/B7 system of T cell costimulation.","volume":"14","author":"Lenschow","year":"1996"},{"key":"b25","series-title":"Annu Rev Immunol","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.iy.11.040193.001203","article-title":"The role of the CD28 receptor during T cell responses to antigen.","volume":"11","author":"Linsley","year":"1993"},{"key":"b26","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3171\/jns.1990.72.1.0102","article-title":"Adoptive immunotherapy of intracerebral metastases in mice.","volume":"72","author":"McCutcheon","year":"1990"},{"key":"b27","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/1097-0215(20000815)87:4<574::AID-IJC18>3.0.CO;2-T","article-title":"Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response.","volume":"87","author":"Meazza","year":"2000"},{"key":"b28","series-title":"Br J Exp Pathol","first-page":"58","article-title":"Immunity to homologous grafted skin: III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.","volume":"29","author":"Medawar","year":"1948"},{"key":"b29","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.gt.3301209","article-title":"B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.","volume":"7","author":"Paul","year":"2000"},{"key":"b30","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.4049\/jimmunol.166.10.6074","article-title":"CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.","volume":"166","author":"Radoja","year":"2001"},{"key":"b31","series-title":"Annu Rev Immunol","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.immunol.17.1.781","article-title":"The central effectors of cell death in the immune system.","volume":"17","author":"Rathmell","year":"1999"},{"key":"b32","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"10399","DOI":"10.1073\/pnas.93.19.10399","article-title":"Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the \u201cimmunologically privileged\u201d central nervous system.","volume":"93","author":"Sampson","year":"1996"},{"key":"b33","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.cgt.7700271","article-title":"Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.","volume":"8","author":"Shiau","year":"2001"},{"key":"b34","series-title":"Science","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.270.5239.1158","article-title":"Unraveling immune privilege.","volume":"270","author":"Streilein","year":"1995"},{"key":"b35","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.cgt.7700023","article-title":"Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.","volume":"6","author":"Visse","year":"1999"},{"key":"b36","series-title":"Eur J Immunol","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/eji.1830220125","article-title":"Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.","volume":"22","author":"Wilbanks","year":"1992"},{"key":"b37","series-title":"J Exp Med","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1084\/jem.182.5.1415","article-title":"A reassessment of the role of B7-1 expression in tumor rejection.","volume":"182","author":"Wu","year":"1995"},{"key":"b38","series-title":"J Immunol","first-page":"2794","article-title":"Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28\/CTLA-4 costimulatory molecules.","volume":"154","author":"Yang","year":"1995"},{"key":"b39","series-title":"J Immunol","first-page":"823","article-title":"B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.","volume":"128","author":"Yokochi","year":"1982"},{"key":"b40","series-title":"Nature","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/45582","article-title":"T-cell co-stimulation through B7RP-1 and ICOS.","volume":"402","author":"Yoshinaga","year":"1999"},{"key":"b41","series-title":"Int Immunol","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/intimm\/12.10.1439","article-title":"Characterization of a new human B7-related protein: B7RP-1 is the ligand to the costimulatory protein ICOS.","volume":"12","author":"Yoshinaga","year":"2000"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/97\/2\/article-p432.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/97\/2\/article-p432.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/97\/2\/article-p432.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T01:19:29Z","timestamp":1679275169000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/97\/2\/article-p432.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":41,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns.2002.97.2.0432","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}